>>> US Gapping down

Gapping down
In reaction to earnings/guidance:

  • DOCN -20.8%, FTNT -18.7%, TNDM -16.2%, OUT -15.2%, MODV -14%, TMDX -12%, SPT -11.2% (also acquires Tagger Media), OPEN -10.1%, RDFN -10.1%, SYNA -9.8%, LASR -9.3%, ABCL -9%, MTZ -8.6%, OMI -7.7%, MWA -7.4%, RMD -7.3%, FND -7%, WPP -6.8%, AMN -5.9%, MCHP -5.7% (also increases dividend), EAF -5.5%, WW -5.3%, AU -5.2%, SQ -5%, BBD -5%, IGMS -4.8%, FNKO -4.6%, MCW -4.6%, PCTY -3.6%, ALTR -3.6%, CLFD -3.6%, POWI -3.5%, CABO -3.5%, GDOT -3.5%, EXR -3.3%, CVCO -3.1% (also authorizes new $100 mln share repurchase program), AAON -3%, NNBR -3%, TIXT -3%, REZI -2.9% (also authorizes new $150 mln share repurchase program), MNST -2.9%, AES -2.9%, GPRE -2.7%, AAPL -2.4%, MERC -2.4%, ATEC -2.3%, CTVA -2.2%, FYBR -2.2%, RRR -2.1%, TXG -2%, DLB -2%, SSP -2%, USM -1.9%, DEN -1.7%, VIR -1.6%, LYB -1.6%, APPN -1.5%, CRSR -1.4%, COIN -1.4%, BE -1.4%, EXPI -1.3%, ICFI -1.3%, FOXF -1.2%, RGA -1.1%, LTHM -1%

Other news:

  • MESO -66.9% (receives Complete Response from FDA for Biologics License Application for steroid-refractory acute graft versus host disease in children)
  • QS -10.2% (prices offering of 37.5 mln shares of common stock for gross proceeds of $300 mln)
  • CARG -8.3% (to delay Q2 earnings) TRIN -7.3% (prices offering of $75.0 mln of shares of its common stock at $14.45 per share)
  • RYI -6.4% (prices previously announced secondary public offering of 4 mln shares of common stock by a significant shareholder an affiliate of Platinum Equity) PANW -6.1% (in sympaty with weak FTNT earnings)
  • HAYW -4.7% (prices offering by selling shareholders)
  • ZS -2.5% (in sympaty with weak FTNT earnings)
  • CRWD -2.5% (in sympaty with weak FTNT earnings)
  • HITI -2.3% (files final base shelf prospectus to replace expired base shelf prospectus for up to an aggregate offering price of C$100,000,000)
  • KWR -2% (stock offering by selling shareholders)
  • ABC -1.7% (Walgreens Boots Alliance (WBA) sells shares of AmerisourceBergen for $1.85 billion of initial proceeds)
  • CYBR -1% (in sympaty with weak FTNT earnings)

Analyst comments:

  • MAX -3.8% (downgraded to Sell from Neutral at Citigroup)
  • CLFD -3.6% (downgraded to Market Perform from Outperform at Northland Capital)
  • MERC -1.7% (downgraded to Mkt Perform from Outperform at Raymond James)
  • ENTG -1.3% (downgraded to Hold from Buy at Craig Hallum)